125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue — Vancouver, Washington

125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue is a clinical research site located in Vancouver, Washington, United States 98684.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue has participated in 1 clinical trials.

Therapeutic areas: Meningitis, Meningococcal Infection.

Sponsors: Novartis.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue?

125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue conducted?

125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue has 1 clinical trials on record. Their work covers Meningitis, Meningococcal Infection.

Is 125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue accredited by Crixeo Health?

125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 125 The Vancouver Clinic/Columbia Tech Center 501 SE 172th Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.